| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.75B | 4.65B | 4.72B | 4.75B | 4.59B |
| Gross Profit | 135.70M | 1.81B | 2.02B | 2.24B | 2.12B |
| EBITDA | 700.80M | 849.80M | 656.20M | 896.70M | 863.60M |
| Net Income | 118.30M | 127.50M | -15.90M | 87.10M | 636.40M |
Balance Sheet | |||||
| Total Assets | 3.10B | 3.66B | 3.81B | 4.41B | 3.83B |
| Cash, Cash Equivalents and Short-Term Investments | 432.00M | 171.40M | 496.50M | 791.40M | 787.70M |
| Total Debt | 1.16B | 1.35B | 1.60B | 2.99B | 1.41B |
| Total Liabilities | 2.38B | 2.95B | 3.17B | 3.66B | 2.95B |
| Stockholders Equity | 710.00M | 696.70M | 633.30M | 740.20M | 876.60M |
Cash Flow | |||||
| Free Cash Flow | 378.70M | 597.80M | 324.00M | 402.30M | -184.80M |
| Operating Cash Flow | 620.50M | 754.20M | 543.30M | 580.20M | 66.80M |
| Investing Cash Flow | -191.10M | -150.90M | -10.20M | 73.00M | 2.08B |
| Financing Cash Flow | -453.50M | -641.50M | -776.30M | -640.90M | -2.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.20B | 15.52 | 16.69% | 1.27% | 1.69% | 276.44% | |
74 Outperform | £4.34B | 10.25 | 11.57% | 2.37% | 9.93% | 1.93% | |
70 Outperform | £1.05B | 8.80 | 19.28% | 3.66% | -6.21% | 0.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | £1.28B | 8.37 | 30.56% | ― | 10.71% | -101.29% | |
47 Neutral | £146.48M | -1.77 | 160.47% | ― | -19.76% | 61.69% | |
42 Neutral | £82.01M | -8.86 | -5.70% | 0.90% | 8.64% | -143.74% |